Nobel laureate Roger Kornberg will join the scientific advisory board of Prize4Life, a nonprofit focused on accelerating the development of treatments and a cure for amyotrophic lateral sclerosis.
“Prize4Life is delighted to welcome such an accomplished and talented scientific mind,” Avi Kremer, co-founder and chief executive officer of Prize4Life, said. “Roger Kornberg is an excellent addition to our (board), which provides a high level of expert knowledge and wise counsel to Prize4Life and is integral to the success of our important mission.”
Kornberg, a professor at Stanford University School of Medicine, won the Nobel in 2006 for seminal research on the molecular basis of eukaryotic transcription, and his lab has continued to elucidate the complex processes by which DNA is unraveled, read and transcribed. In a statement, Kornberg called the nonprofit’s mission “imperative” and said he was looking forward to joining the board. Prize4Life was founded in 2006 by Kremer, who was diagnosed with ALS at age 29.